Digital Content

We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. We’ll assume you’re ok with this, but you can opt out if you wish. See our 

Footer

Column Name Goes Here

Footer V2

2024 Event

Event Global

New HLTH Insights Programs

Become a Hosted Buyer

Become a Sponsor/Exhibitor

Apply for Media Pass

Promote Your Presence

2023 Event

Event Global Footer

Startup Opportunities

Hotel

2022 Event

LLC Global

2021 Event

LLC Menu Official

LLC Menu

A New Dawn in Early Cancer Detection with Dr. Megan Hall of GRAIL

In this groundbreaking era of healthcare, the opportunity to revolutionize cancer outcomes has never been more promising. With cutting-edge testing techniques, early detection strategies, and the power of AI, the landscape of cancer care is evolving to save lives and enhance patient well-being like never before. In this episode of HLTH Matters, Dr. Gautam Gulati sits down with Dr. Megan Hall to discuss the future of cancer detection and prevention through early genetic testing.  <a href="https://www.linkedin.com/in/megan-p-hall-2401068/" target="_blank">Dr. Megan Hall</a> is the Vice President of Corporate Affairs at <a href="https://grail.com/" target="_blank">GRAIL</a>. With a Ph.D. in microbiology, immunology, and molecular genetics she is dedicated to making early cancer detection and prevention accessible on a population scale. As Dr. Hall says, “I was enamored of the mission to detect cancer early when it can be cured. That&#39;s a huge problem that we have to be frank have not made great headway on in the 50 years that we&#39;ve been waging this war on cancer.”  Now she shares how GRAIL&#39;s flagship product, <a href="https://grail.com/galleri-test/" target="_blank">Galleri</a>, is using advanced technology, including DNA methylation analysis and artificial intelligence (AI), to detect and predict cancer in a non-invasive way.  Listen in as we explore the potential cost savings and improved outcomes with early cancer detection, and GRAIL&#39;s efforts to make this transformative technology accessible to a broader population.  Topics Covered<ul><li>The significance of early detection in cancer care</li><li>The role of DNA methylation in cancer detection</li><li>The importance of evaluating the accuracy of cancer screening and the power of positive predictive value</li><li>The need for education across the cancer care continuum</li><li>The potential for healthcare cost savings with early cancer detection</li><li>The role of AI and machine learning in cancer detection</li><li>GRAIL&#39;s focus on expanding access to cancer screening and its plans for future products</li></ul>Connect with Dr. Megan Hall<ul><li>Dr. Hall on <a href="https://www.linkedin.com/in/megan-p-hall-2401068/" target="_blank">LinkedIn</a> </li></ul>Connect with Dr. Gautam Gulati &amp; Dr. Jessica Shepherd <ul><li><a href="https://www.hlth.com/" target="_blank">HLTH</a></li><li>Dr. Gulati on <a href="https://twitter.com/drgautamgulati" target="_blank">X</a> </li><li>Dr. Gulati on <a href="https://www.linkedin.com/in/gautamgulati" target="_blank">LinkedIn</a></li><li><a href="https://www.drjessicashepherd.com/about" target="_blank">Dr. Jessica Shepherd MD </a></li><li>Dr. Shepherd on <a href="https://twitter.com/JShepherd_MD" target="_blank">X</a> </li></ul>Resources <ul><li><a href="https://grail.com/" target="_blank">GRAIL</a> </li><li><a href="https://grail.com/galleri-test/" target="_blank">Galleri Test - GRAIL </a></li></ul>

S4 E41: A New Dawn in Early Cancer Detection with Dr. Megan Hall of GRAIL

Head of Corporate Affairs, Distinguished Scientist

Extending Healthy Longevity with AI—featuring Alex Zhavoronkov of Insilico Medic

On this episode of HLTH Matters, Alex joins Dr. Kuku and Dr. Shlain to discuss his work in the field of longevity biotechnology, describing his particular focus on extending our most productive years as opposed to the end of life. He introduces us to the new science around aging clocks and weighs in on the possibilities of using their data to reverse age-associated pathologies. Listen in for Alex’s insight around the potential for AI to influence our political systems and learn how a sole focus on rejuvenation rate would support global economic growth.

S1 Ep7: Extending Healthy Longevity with AI—featuring Alex Zhavoronkov of Insilico Medicine

Founder and CEO

Driving Meaningful Progress in Health Equity—featuring Judith Kulich

Health equity disparities are a societal problem that will only worsen if we do nothing about it. In this episode, Judith Kulich, Managing Principal of Patient Health and Equity at ZS, addresses disparities in care and health equity gaps to improve patients’ experiences and outcomes. She provides several examples illustrating the impact of health equity disparities reflected on patient casualties and costs. She explains why it’s so hard to tackle because of insufficient communication, data, ownership, and representation across different organizations, among other factors. Judith discusses drivers of health that affect how patients either engage with their healthcare or drop out of it and recommends a few steps that payers and providers can take to make a difference in diversity and inclusion. Finally, she highlights what she calls “bright spots” like focus and teamwork, things that are already happening that move towards more health equity. Tune in to learn how Judith Kulich has been working with different healthcare sectors to address disparities and inequities in care!  About Judith Kulich:Judith serves as ZS’s lead for patient health and equity, focused on partnering with clients across the healthcare industry to drive meaningful progress in health equity. She is also an elected member of ZS’s Shareholders’ Council where she serves as the chair of the ESG Committee and leads the ZS Practice Council. Judith has spent much of her 20-plus years in the healthcare industry focused on drug development and bringing medicines to market globally. In recent years, she has expanded her work into healthcare payers and providers, bringing sectors together to address disparities in care and global health inequities. She has led industry collaborations and ZS’s investments and actively contributed to global health equity partnerships. Judith established and ran ZS’s pipeline and launch strategy practice area. Internally, she led ZS’s San Francisco office and was one of the founders of Women@ZS and our philanthropic arm, ZS Cares, both of which she is still actively involved in today. Judith holds an MBA from the Haas School of Business at the University of California, Berkeley, and a B.S. in industrial engineering and operations research from the University of California, Berkeley. Things You’ll Learn:<ul><li>74,000 black Americans die every year in the United States due to inequities.</li><li>The economic costs of health inequities in the US are over $300 billion annually.</li><li>There is a lack of representation among minority groups. </li><li>There is also a lack of training and incentives to adopt behaviors that bolster equity across healthcare.</li><li>A third of patients who drop out of their care do so because of drivers of health like transportation, food, and housing, which require their partial or full financial support. </li><li>The other two-thirds of patients that drop out of their programs need help with awareness and care coordination.</li><li>Life sciences stakeholders can expand sites of care and increase representation to improve access.</li><li>Targeting specific disease areas and communities is a good start to closing disparity gaps.</li></ul> Resources:<ul><li>Connect with and follow Judith Kulich on <a href="https://www.linkedin.com/in/judithkulich/" target="_blank">LinkedIn</a>.</li><li>Follow ZS on <a href="https://www.linkedin.com/company/zs-associates/" target="_blank">LinkedIn</a>.</li><li>Explore the <a href="https://www.zs.com/" target="_blank">ZS Website</a>!</li></ul>

S3 Ep11: Driving Meaningful Progress in Health Equity—featuring Judith Kulich

Principal, Patient Health & Equity Lead

The Beat: AI's Impact on Healthcare Growth

Imagine a platform seamlessly integrating virtual, in-person, and home care through cutting-edge digital and AI technologies for a holistic healthcare experience In this episode, Ashok Chennuru, Global Chief Data and Insights Officer at Elevance Health shares insights on the strategies and initiatives at Elevance Health, the largest health insurer in the country. Ashok shares the mental map of Elevance Health&#39;s three businesses, highlighting the comprehensive portfolio of products and solutions they offer to serve over 119 million lives. He also delves into the strategic priorities for growth in each segment, shedding light on the use of digital platforms, data-driven insights, and the harnessing of AI to drive meaningful advances. Ashok emphasizes how AI has been incorporated into every function across the organization, including streamlining operations, predictive analytics, and enhancing consumer and provider experiences. Ashok provides insights into Elevance Health&#39;s engagement with the startup ecosystem, detailing the criteria for vendor partnerships and the focus on scalable opportunities that benefit not only Elevance Health but also the broader healthcare landscape. Join us as we explore the intersection of healthcare, technology, and responsible AI with Ashok Chennuru. About Ashok Chennuru:Ashok Chennuru serves as Global Chief Data &amp; Insights Officer and Interim Lead of Carelon Digital Platforms. Ashok oversees the responsibility of carrying out the vision of Carelon Digital Platforms and bringing to life digital solutions that enhance healthcare outcomes and accelerate growth by reimagining care delivery, operations, and consumer experiences. He uses data analytics to drive a digital-first approach across the company&#39;s artificial intelligence (AI), exponential technology, service experience, and innovation portfolios, as well as the commercialization efforts of digital capabilities for consumers, care providers, and the health ecosystem. Prior to his current role, Ashok served as Vice President of Enterprise Data and Analytics for Anthem, Inc. for 8 years, as Director of Enterprise Information Architecture at Wellpoint for 6 years, and as Enterprise Technologist at Liberty Mutual for 6 years. He has over two decades of industry experience, where he has played a critical role in driving innovation and growth. Prior to joining Elevance Health, Ashok led the Information Business Intelligence team at Liberty Mutual and focused on delivering analytics to key business areas like Actuarial &amp; Finance. Preceding Liberty Mutual, Ashok worked in software giants SAP and Oracle as a software development engineer focused on analytics products.Ashok holds a master’s degree (MS) in Computer Science from the University of Missouri and a BS in Computer Science and Engineering from Madurai University in India. <a href="https://www.ahip.org/people/ashok-chennuru" target="_blank">Source</a> Things You’ll Learn:<ul><li>Elevance Health utilizes AI for automation, analytics, and improving consumer and provider experiences. </li><li>By leveraging a robust data set from administrative claims, EMR data, and social and behavioral data, Elevance Health drives AI-driven insights for personalized care recommendations and closing care gaps.</li><li>Elevance Health emphasizes responsible AI, ensuring fairness, inclusivity, robustness, security, traceability, and accountability in its AI practices. </li><li>The core priority of using digital platforms for health is to enhance the consumer experience, including AI-driven solutions like symptom checkers and virtual care.</li><li>The use of AI has already delivered tangible results, from personalized provider matches to streamlining prior authorizations, significantly improving consumer and provider experiences while driving operational efficiencies.</li></ul> Resources:<ul><li>Connect with and follow Ashok Chennuru on <a href="https://www.linkedin.com/in/ashok-chennuru-832711/" target="_blank">LinkedIn</a>.</li><li>Follow Accolade on <a href="https://www.linkedin.com/company/elevance-health/" target="_blank">LinkedIn</a> and visit their <a href="https://www.elevancehealth.com/" target="_blank">website</a>.</li></ul>

S1 E1: The Beat: AI's Impact on Healthcare Growth

Vice President, Global Chief Data & Insights Officer

Podcast

S4 E41: A New Dawn in Early Cancer Detection with Dr. Megan Hall of GRAIL

FEATURING